UKRI-2542 An Economic Evaluation of BBSRCs Translational funding
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
03 May 2023
Description
**This is a contract award notice, not a call for competition.** UKRI have a requirement for an Economic Evaluation of BBSRC’s Translational funding. The aim of this evaluation activity is to conduct an outcomes and impact evaluation of BBSRC’s investments in translational funding since 2004. This study seeks to capture the effectiveness of the Follow on Fund and the Impact Acceleration Accounts in achieving their strategic aims and monetise the economic impacts delivering a Gross Value-Added figure and will include some in depth case studies. The study will provide a description of how BBSRC / UKRI has created leverage and opportunity for the academic research base, individual businesses, bioscience entrepreneurs and the wider economy. The contract is expected to commence in February/March 2023 and be completed by 30th October 2023, with optional time only extensions of up to 4 months period from commencement of the Contract subject to UKRI approval.
Scope
- Reference
- UKRI-2542
- Commercial tool
- Standalone contract
- Main category
- services
- CPV classifications
- 73000000
- Contract locations
- Swindon
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Quality | 90 | quality | — |
| Price | 10 | cost | — |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—